Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Cancer Antibody Drug Conjugates market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Antibody Drug Conjugatesmarket, defines the market attractiveness level of Cancer Antibody Drug Conjugates market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cancer Antibody Drug Conjugates industry, describes the types of Cancer Antibody Drug Conjugates market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Antibody Drug Conjugates market and the development prospects and opportunities of Cancer Antibody Drug Conjugates industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Antibody Drug Conjugates market in Chapter 13.
By Player:
Progenics Pharmaceuticals
Millennium
Helix BioPharma
Seattle Genetics
Stem CentRx
Roche
AbGenomics Corporation
UCB
Bristol-Myers Squibb
Biogen Idec
Novartis
Biotest AG
Nordic Nanovector
Viventia Biotechnologies
PDL BioPharma
Merck
AbbVie
By Type:
First & Second Generation ADCs
Third Generation ADCs
By End-User:
Hospitals
Clinics
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cancer Antibody Drug Conjugates Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cancer Antibody Drug Conjugates Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cancer Antibody Drug Conjugates Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cancer Antibody Drug Conjugates Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cancer Antibody Drug Conjugates Market Analysis and Outlook to 2022
-
7.1 Global Cancer Antibody Drug Conjugates Consumption (2017-2022)
-
7.2 United States Cancer Antibody Drug Conjugates Consumption (2017-2022)
-
7.3 Europe Cancer Antibody Drug Conjugates Consumption (2017-2022)
-
7.4 China Cancer Antibody Drug Conjugates Consumption (2017-2022)
-
7.5 Japan Cancer Antibody Drug Conjugates Consumption (2017-2022)
-
7.6 India Cancer Antibody Drug Conjugates Consumption (2017-2022)
-
7.7 South Korea Cancer Antibody Drug Conjugates Consumption (2017-2022)
8 Region and Country-wise Cancer Antibody Drug Conjugates Market Analysis and Outlook to 2028
-
8.1 Global Cancer Antibody Drug Conjugates Consumption Forecast (2022-2028)
-
8.2 United States Cancer Antibody Drug Conjugates Consumption Forecast (2022-2028)
-
8.3 Europe Cancer Antibody Drug Conjugates Consumption Forecast (2022-2028)
-
8.4 China Cancer Antibody Drug Conjugates Consumption Forecast (2022-2028)
-
8.5 Japan Cancer Antibody Drug Conjugates Consumption Forecast (2022-2028)
-
8.6 India Cancer Antibody Drug Conjugates Consumption Forecast (2022-2028)
-
8.7 South Korea Cancer Antibody Drug Conjugates Consumption Forecast (2022-2028)
9 Global Cancer Antibody Drug Conjugates Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Antibody Drug Conjugates Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global First & Second Generation ADCs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Third Generation ADCs Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Antibody Drug Conjugates Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Cancer Antibody Drug Conjugates Market Outlook by Types and Applications to 2028
-
10.1 Global Cancer Antibody Drug Conjugates Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global First & Second Generation ADCs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Third Generation ADCs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cancer Antibody Drug Conjugates Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Cancer Antibody Drug Conjugates Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cancer Antibody Drug Conjugates Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cancer Antibody Drug Conjugates Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cancer Antibody Drug Conjugates Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cancer Antibody Drug Conjugates Market Competitive Analysis
-
14.1 Progenics Pharmaceuticals
-
14.1.1 Progenics Pharmaceuticals Company Details
-
14.1.2 Progenics Pharmaceuticals Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Progenics Pharmaceuticals Cancer Antibody Drug Conjugates Product and Service
-
14.2 Millennium
-
14.2.1 Millennium Company Details
-
14.2.2 Millennium Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Millennium Cancer Antibody Drug Conjugates Product and Service
-
14.3 Helix BioPharma
-
14.3.1 Helix BioPharma Company Details
-
14.3.2 Helix BioPharma Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Helix BioPharma Cancer Antibody Drug Conjugates Product and Service
-
14.4 Seattle Genetics
-
14.4.1 Seattle Genetics Company Details
-
14.4.2 Seattle Genetics Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Seattle Genetics Cancer Antibody Drug Conjugates Product and Service
-
14.5 Stem CentRx
-
14.5.1 Stem CentRx Company Details
-
14.5.2 Stem CentRx Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Stem CentRx Cancer Antibody Drug Conjugates Product and Service
-
14.6 Roche
-
14.6.1 Roche Company Details
-
14.6.2 Roche Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Roche Cancer Antibody Drug Conjugates Product and Service
-
14.7 AbGenomics Corporation
-
14.7.1 AbGenomics Corporation Company Details
-
14.7.2 AbGenomics Corporation Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AbGenomics Corporation Cancer Antibody Drug Conjugates Product and Service
-
14.8 UCB
-
14.8.1 UCB Company Details
-
14.8.2 UCB Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 UCB Cancer Antibody Drug Conjugates Product and Service
-
14.9 Bristol-Myers Squibb
-
14.9.1 Bristol-Myers Squibb Company Details
-
14.9.2 Bristol-Myers Squibb Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Bristol-Myers Squibb Cancer Antibody Drug Conjugates Product and Service
-
14.10 Biogen Idec
-
14.10.1 Biogen Idec Company Details
-
14.10.2 Biogen Idec Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Biogen Idec Cancer Antibody Drug Conjugates Product and Service
-
14.11 Novartis
-
14.11.1 Novartis Company Details
-
14.11.2 Novartis Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Novartis Cancer Antibody Drug Conjugates Product and Service
-
14.12 Biotest AG
-
14.12.1 Biotest AG Company Details
-
14.12.2 Biotest AG Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Biotest AG Cancer Antibody Drug Conjugates Product and Service
-
14.13 Nordic Nanovector
-
14.13.1 Nordic Nanovector Company Details
-
14.13.2 Nordic Nanovector Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Nordic Nanovector Cancer Antibody Drug Conjugates Product and Service
-
14.14 Viventia Biotechnologies
-
14.14.1 Viventia Biotechnologies Company Details
-
14.14.2 Viventia Biotechnologies Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Viventia Biotechnologies Cancer Antibody Drug Conjugates Product and Service
-
14.15 PDL BioPharma
-
14.15.1 PDL BioPharma Company Details
-
14.15.2 PDL BioPharma Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 PDL BioPharma Cancer Antibody Drug Conjugates Product and Service
-
14.16 Merck
-
14.16.1 Merck Company Details
-
14.16.2 Merck Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Merck Cancer Antibody Drug Conjugates Product and Service
-
14.17 AbbVie
-
14.17.1 AbbVie Company Details
-
14.17.2 AbbVie Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 AbbVie Cancer Antibody Drug Conjugates Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cancer Antibody Drug Conjugates
-
Figure Cancer Antibody Drug Conjugates Picture
-
Table Global Cancer Antibody Drug Conjugates Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Antibody Drug Conjugates Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Antibody Drug Conjugates Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cancer Antibody Drug Conjugates Consumption by Country (2017-2022)
-
Figure United States Cancer Antibody Drug Conjugates Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Antibody Drug Conjugates Consumption and Growth Rate (2017-2022)
-
Figure China Cancer Antibody Drug Conjugates Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Antibody Drug Conjugates Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Antibody Drug Conjugates Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Antibody Drug Conjugates Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Antibody Drug Conjugates Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Antibody Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Antibody Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cancer Antibody Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Antibody Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Antibody Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Antibody Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global First & Second Generation ADCs Consumption and Growth Rate (2017-2022)
-
Figure Global Third Generation ADCs Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global First & Second Generation ADCs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Third Generation ADCs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cancer Antibody Drug Conjugates Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cancer Antibody Drug Conjugates Export by Region (Top 5 Countries) (2017-2028)
-
Table Progenics Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Progenics Pharmaceuticals Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Progenics Pharmaceuticals Cancer Antibody Drug Conjugates Product and Service
-
Table Millennium (Foundation Year, Company Profile and etc.)
-
Table Millennium Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Millennium Cancer Antibody Drug Conjugates Product and Service
-
Table Helix BioPharma (Foundation Year, Company Profile and etc.)
-
Table Helix BioPharma Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Helix BioPharma Cancer Antibody Drug Conjugates Product and Service
-
Table Seattle Genetics (Foundation Year, Company Profile and etc.)
-
Table Seattle Genetics Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seattle Genetics Cancer Antibody Drug Conjugates Product and Service
-
Table Stem CentRx (Foundation Year, Company Profile and etc.)
-
Table Stem CentRx Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Stem CentRx Cancer Antibody Drug Conjugates Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Cancer Antibody Drug Conjugates Product and Service
-
Table AbGenomics Corporation (Foundation Year, Company Profile and etc.)
-
Table AbGenomics Corporation Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbGenomics Corporation Cancer Antibody Drug Conjugates Product and Service
-
Table UCB (Foundation Year, Company Profile and etc.)
-
Table UCB Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Cancer Antibody Drug Conjugates Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Cancer Antibody Drug Conjugates Product and Service
-
Table Biogen Idec (Foundation Year, Company Profile and etc.)
-
Table Biogen Idec Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Idec Cancer Antibody Drug Conjugates Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Cancer Antibody Drug Conjugates Product and Service
-
Table Biotest AG (Foundation Year, Company Profile and etc.)
-
Table Biotest AG Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biotest AG Cancer Antibody Drug Conjugates Product and Service
-
Table Nordic Nanovector (Foundation Year, Company Profile and etc.)
-
Table Nordic Nanovector Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nordic Nanovector Cancer Antibody Drug Conjugates Product and Service
-
Table Viventia Biotechnologies (Foundation Year, Company Profile and etc.)
-
Table Viventia Biotechnologies Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Viventia Biotechnologies Cancer Antibody Drug Conjugates Product and Service
-
Table PDL BioPharma (Foundation Year, Company Profile and etc.)
-
Table PDL BioPharma Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table PDL BioPharma Cancer Antibody Drug Conjugates Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Cancer Antibody Drug Conjugates Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Cancer Antibody Drug Conjugates Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Cancer Antibody Drug Conjugates Product and Service
-
